Protein detail

TN13B

Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]

Entry name
TN13B
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
8
Transmembrane count
1
Protein classification
Cancer-related genesCD markersFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins
Basic Information
Protein Names
Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]
Protein Class (7)
Cancer-related genesCD markersFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins
Protein Function (5)
  • Predicted intracellular proteins
  • CD markers
  • Cancer-related genes:Candidate cancer biomarkers
  • Predicted secreted proteins
  • FDA approved drug targets:Biotech drugs
Transmembrane
47..67; Helical; Signal-anchor for type II membrane protein
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (7)
BAFFBLYSCD257TALL-1TALL1THANKTNFSF20
Gene Description
TNF superfamily member 13b
Chromosome
13
Position
108251240-108308484
Supporting publications (n)
8
EVMP confidence score
0.38
Fluorescence & Localization
Tissue SpecifictestisCell SpecificCardiomyocytes
Function & Pathway
Relations & Evidence73

Ligand-Receptor Signaling (64)

64 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembranetransmembrane_predictedPhobiusYes
transmembrane_phobiustransmembrane_predictedAlmen2009Yes
transmembrane_sosuitransmembrane_predictedAlmen2009Yes
transmembrane_tmhmmtransmembrane_predictedAlmen2009Yes
Page 7 of 7Previous

Regulatory Interaction Network (2)

2 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
TN13BQ9Y275TR13CQ96RJ3YesYesiTALKGuide2Pharma_LRdbICELLNETSIGNORHINTInnateDBUniProt_LRdbHPMR_talklrHPMRCellChatDBHPRD_LRdbtalklrscConnectHPRDRamilowski2015_Baccin2019Guide2Pharma_CellinkerWangRamilowski2015HPMR_LRdbCellPhoneDBGuide2Pharma_talklrHPRD_talklrBaccin2019CellinkerSTRING_talklrEMBRACECellCallGuide2PharmaCellTalkDBFantom5_LRdbHPMR_CellinkerconnectomeDB2020LRdbICELLNET:11239407connectomeDB2020:15851487HINT:12755599HINT:12721620HINT:12571250Baccin2019:15851487LRdb:15851487CellTalkDB:15851487LRdb:12721620Baccin2019:12721620HINT:12715002HPRD:12721620InnateDB:12571250HINT:22505257Cellinker:12721620Baccin2019:11509692SIGNOR:15644327LRdb:11509692connectomeDB2020:12721620connectomeDB2020:11509692HPRD:11509692SIGNOR:15851487Cellinker:11509692HPMR:15851487Cellinker:15851487
TN13BQ9Y275TR13BO14836YesYesiTALKGuide2Pharma_LRdbICELLNETSIGNORHINTUniProt_LRdbDIPLit-BM-17HPMR_talklrCellChatDBHPRD_LRdbtalklrscConnectHPRDIntActRamilowski2015_Baccin2019Guide2Pharma_CellinkerWangRamilowski2015HPMR_LRdbCellPhoneDBGuide2Pharma_talklrHPRD_talklrBaccin2019CellinkerSTRING_talklrEMBRACEGuide2PharmaCellTalkDBFantom5_LRdbHPMR_CellinkerconnectomeDB2020SPIKE_LCLRdbICELLNET:11239407SPIKE_LC:17145710CellTalkDB:10956646IntAct:10956646IntAct:10801128HINT:10880535IntAct:10880535LRdb:10956646Baccin2019:10801128HPRD:10801128Lit-BM-17:10801128LRdb:11HINT:10956646Lit-BM-17:10956646SPIKE_LC:10801128DIP:10956646Lit-BM-17:10880535HINT:10801128Cellinker:10956646connectomeDB2020:10801128SIGNOR:10956646connectomeDB2020:10956646Cellinker:10801128Baccin2019:10956646

Protein Complex Composition (6)

6 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
TALL1 homo-oligomer complexTNFSF13BQ9Y27510CORUMPDBPDB:1kxgPDB:4zchPDB:1kd7CORUM:5691PDB:6fxnPDB:1jh5PDB:1osg14749821
FAM118AFHIP2AMAP3K15MAP3K5MAP3K6PDSS1TNFSF13BO95382Q5T2R2Q5W0V3Q6ZN16Q99683Q9NWS6Q9Y2750:0:0:0:0:0:0hu.MAP
FHIP2AHOOK2MAP3K15MAP3K5TNFSF13BQ5W0V3Q6ZN16Q96ED9Q99683Q9Y2750:0:0:0:0hu.MAP2
FHIP2AMAP3K15MAP3K5TNFSF13BQ5W0V3Q6ZN16Q99683Q9Y2750:0:0:0hu.MAP
FAM118AMAP3K15MAP3K5TNFSF13BQ6ZN16Q99683Q9NWS6Q9Y2750:0:0:0hu.MAP
TNFRSF13CTNFSF13BQ96RJ3Q9Y2758:10PDBPDB:4v46PDB:8zujPDB:3v56PDB:1oqe

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Size Exclusion ChromatographyMass spectrometry138343172
Sequence, Structure & Domains

Sequences

Length
285
Mass
31,223
Sequence
MDDSTEREQSRLTSCLKKREEMKLKECVSILPRKESPSVRSSKDGKLLAATLLLALLSCCLTVVSFYQVAALQGDLASLRAELQGHHAEKLPAGAGAPKAGLEEAPAVTAGLKIFEPPAPGEGNSSQNSRNKRAVQGPEETVTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLYTDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQLAIPRENAQISLDGDVTFFGALKLL
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=Q9Y275-1; Sequence=Displayed; Name=2; Synonyms=DeltaBAFF; IsoId=Q9Y275-2; Sequence=VSP_041183; Name=3; Synonyms=Delta4BAFF; IsoId=Q9Y275-3; Sequence=VSP_047591, VSP_047592
Alternative Sequence
142..160; Missing (in isoform 2); 162..164; SYT -> FIY (in isoform 3); 165..285; Missing (in isoform 3)

3D Structural Models

Turn
219..222; 274..276
Beta Strand
146..151; 158..160; 163..165; 168..181; 184..187; 191..201; 205..215; 225..235; 238..240; 243..253; 258..265; 277..283
3D Structure
Electron microscopy (1); X-ray crystallography (11)

Domain & Motif Annotations

Domain (FT)
145..284; THD
Region
114..138; Disordered
Protein Families
Tumor necrosis factor family
Sequence Similarities
Belongs to the tumor necrosis factor family.
Clinical Relevance
Disease Involvement (2)
Cancer-related genesFDA approved drug targets
Biomarker
Approved; Discontinued in Phase 1; Phase 3; Discontinued in Phase 2
Drug Targets
FDA approved drug targets
Antibody (2)
Interaction Protein (3)
ENSG00000108424ENSG00000124207ENSG00000240505
Interaction Count
3
Interaction Dataset
intact_biogrid
Supporting Publications8
PMIDTitleRelated sentences
26826536[Cardiovascular risk study in patients with renin-angiotensin system blockade by means of the proteone of circulating extracellular vesicles].No related sentences available
34064677Ubiquinone Metabolism and Transcription HIF-1 Targets Pathway Are Toxicity Signature Pathways Present in Extracellular Vesicles of Paraquat-Exposed Human Brain Microvascular Endothelial Cells.No related sentences available
37322475Comprehensive profiling of extracellular vesicles in uveitis and scleritis enables biomarker discovery and mechanism exploration.No related sentences available
38113368In-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum.No related sentences available
38207106Proteomic, Metabolomic, and Fatty Acid Profiling of Small Extracellular Vesicles from Glioblastoma Stem-Like Cells and Their Role in Tumor Heterogeneity.No related sentences available
39207047The trajectory of vesicular proteomic signatures from HBV-HCC by chitosan-magnetic bead-based separation and DIA-proteomic analysis.No related sentences available
40840701Multiomics analysis to evaluate the enrichment of extracellular vesicles from human plasma.No related sentences available
41307968Extracellular Vesicles Define Discrete Nano-Based Niches Within the Human Haematopoietic System.No related sentences available